GB0303615D0 - Use of organic compounds - Google Patents

Use of organic compounds

Info

Publication number
GB0303615D0
GB0303615D0 GBGB0303615.9A GB0303615A GB0303615D0 GB 0303615 D0 GB0303615 D0 GB 0303615D0 GB 0303615 A GB0303615 A GB 0303615A GB 0303615 D0 GB0303615 D0 GB 0303615D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0303615.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0303615.9A priority Critical patent/GB0303615D0/en
Publication of GB0303615D0 publication Critical patent/GB0303615D0/en
Priority to PL376755A priority patent/PL376755A1/pl
Priority to MXPA05008711A priority patent/MXPA05008711A/es
Priority to BRPI0407529-3A priority patent/BRPI0407529A/pt
Priority to EP04711348A priority patent/EP1596865A1/en
Priority to AU2004212327A priority patent/AU2004212327A1/en
Priority to JP2006501857A priority patent/JP2006517940A/ja
Priority to CNA2004800044023A priority patent/CN1750826A/zh
Priority to CA002516265A priority patent/CA2516265A1/en
Priority to PCT/EP2004/001451 priority patent/WO2004071513A1/en
Priority to US10/545,410 priority patent/US20060166967A1/en
Priority to US12/261,655 priority patent/US20090054404A1/en
Priority to US12/633,231 priority patent/US20100120746A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
GBGB0303615.9A 2003-02-17 2003-02-17 Use of organic compounds Ceased GB0303615D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB0303615.9A GB0303615D0 (en) 2003-02-17 2003-02-17 Use of organic compounds
PCT/EP2004/001451 WO2004071513A1 (en) 2003-02-17 2004-02-16 Use of r-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain
JP2006501857A JP2006517940A (ja) 2003-02-17 2004-02-16 神経障害性疼痛におけるｒ−１０−ヒドロキシ−１０，１１−ジヒドロ−カルバマゼピンの使用
MXPA05008711A MXPA05008711A (es) 2003-02-17 2004-02-16 Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
BRPI0407529-3A BRPI0407529A (pt) 2003-02-17 2004-02-16 uso de r-10-hidróxi-10,11-dihidro-carbamazepina em dor neuropática
EP04711348A EP1596865A1 (en) 2003-02-17 2004-02-16 Use of r-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain
AU2004212327A AU2004212327A1 (en) 2003-02-17 2004-02-16 Use of R-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain
PL376755A PL376755A1 (pl) 2003-02-17 2004-02-16 Zastosowanie R-10-hydroksy-10,11-dihydrokarbamazepiny w bólach neuropatycznych
CNA2004800044023A CN1750826A (zh) 2003-02-17 2004-02-16 R－10－羟基－10,11－二氢－卡马西平在神经病性疼痛中的应用
CA002516265A CA2516265A1 (en) 2003-02-17 2004-02-16 Use of r-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain
US10/545,410 US20060166967A1 (en) 2003-02-17 2005-02-16 Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain
US12/261,655 US20090054404A1 (en) 2003-02-17 2008-10-30 Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain
US12/633,231 US20100120746A1 (en) 2003-02-17 2009-12-08 Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0303615.9A GB0303615D0 (en) 2003-02-17 2003-02-17 Use of organic compounds

Publications (1)

Publication Number Publication Date
GB0303615D0 true GB0303615D0 (en) 2003-03-19

Family

ID=9953162

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0303615.9A Ceased GB0303615D0 (en) 2003-02-17 2003-02-17 Use of organic compounds

Country Status (11)

Country Link
US (3) US20060166967A1 (https=)
EP (1) EP1596865A1 (https=)
JP (1) JP2006517940A (https=)
CN (1) CN1750826A (https=)
AU (1) AU2004212327A1 (https=)
BR (1) BRPI0407529A (https=)
CA (1) CA2516265A1 (https=)
GB (1) GB0303615D0 (https=)
MX (1) MXPA05008711A (https=)
PL (1) PL376755A1 (https=)
WO (1) WO2004071513A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1879590A1 (en) * 2005-05-06 2008-01-23 Portela & Ca., S.A. Eslicarbazepine acetate and methods of use
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0517740D0 (en) * 2005-08-31 2005-10-12 Novartis Ag Organic compounds
GB0603008D0 (en) * 2006-02-14 2006-03-29 Portela & Ca Sa Method
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
WO2011017319A1 (en) * 2009-08-03 2011-02-10 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods of treating disorders associated with protein polymerization
US8809617B2 (en) 2009-11-05 2014-08-19 The University of Pittsburgh—Of the Commonwealth System of Higher Education Automated high-content live animal drug screening using C. elegans
US9072772B2 (en) 2009-11-05 2015-07-07 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of treating disorders associated with protein aggregation
CN116063231A (zh) * 2021-10-29 2023-05-05 上药康丽（常州）药业有限公司 一种s-利卡西平的回收方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505101A (de) * 1969-03-31 1971-03-31 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
US5534495A (en) * 1993-05-25 1996-07-09 Advanced Peptides And Biotechnology Sciences Treatment of non-HIV neuropathic pain syndromes
US5688830A (en) * 1996-01-25 1997-11-18 Syntex (U.S.A.) Inc. Treatment of neuropathic pain
GB0112812D0 (en) * 2001-05-25 2001-07-18 Portela & Ca Sa Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom
KR20050044396A (ko) * 2001-11-12 2005-05-12 노파르티스 아게 정동 및 주의력 장애 및 신경병성 통증 치료용 의약제조에 사용하기 위한 모노히드록시카르바마제핀
WO2004014391A1 (en) * 2002-08-06 2004-02-19 Novartis Ag Use of carboxamides for the treatment of tinnitus
GB0223224D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
MXPA05008711A (es) 2005-10-05
EP1596865A1 (en) 2005-11-23
US20090054404A1 (en) 2009-02-26
WO2004071513A1 (en) 2004-08-26
PL376755A1 (pl) 2006-01-09
US20060166967A1 (en) 2006-07-27
BRPI0407529A (pt) 2006-02-14
CN1750826A (zh) 2006-03-22
JP2006517940A (ja) 2006-08-03
AU2004212327A1 (en) 2004-08-26
CA2516265A1 (en) 2004-08-26
US20100120746A1 (en) 2010-05-13

Similar Documents

Publication Publication Date Title
EG24716A (en) Combination of organic compounds
GB0212412D0 (en) Combination of organic compounds
IL209964A0 (en) Use of organic compounds
GB0301259D0 (en) Organic compounds
GB0303503D0 (en) Organic compounds
IL174927A0 (en) Use of organic compounds
GB0303615D0 (en) Use of organic compounds
GB0302876D0 (en) Organic compounds
GB0300095D0 (en) Organic compounds
GB0302748D0 (en) Organic compounds
GB0303613D0 (en) Use of organic compounds
GB0301471D0 (en) Organic compounds
GB0301938D0 (en) Organic compounds
GB0302436D0 (en) Use of organic compounds
GB0303614D0 (en) Use of organic compounds
GB0302091D0 (en) Use of organic compounds
GB0323829D0 (en) Use of organic compounds
GB0307281D0 (en) Use of organic compounds
GB0307278D0 (en) Use of organic compounds
GB0303616D0 (en) Use of organic compounds
GB0303506D0 (en) Organic compounds
GB0302991D0 (en) Organic compounds
GB0306071D0 (en) Organic compounds
GB0306070D0 (en) Organic compounds
HK1101276A (en) Use of organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)